Search Options Stock News and Analysis from Schaeffer's

AbbVie Stock Inching Toward Highs Amid Drug Sale Talks

https://www.schaeffersresearch.com/content/news/2021/03/16/abbvie-stock-inching-toward-highs-amid-drug-sale-talks

3/16/2021 10:19 AM

AbbVie Inc (NYSE:ABBV) is in the spotlight this morning, after news that the pharmaceutical company is in talks to sell a $5 billion portfolio of women's drugs. According to Reuters, the company acqui...

Today's Stock Market News & Events: 10/30/2020

https://www.schaeffersresearch.com/content/news/2020/10/30/todays-stock-market-news-events-10-30-2020

10/30/2020 8:06 AM

Yesterday's upbeat economic data lifted the market. U.S. gross domestic product (GDP) data came in better than expected, posting its fastest expansion ever, while initial jobless claims fell to 751,00...

AbbVie Stock Higher After Another Collaboration

https://www.schaeffersresearch.com/content/news/2020/06/25/abbvie-stock-higher-after-another-collaboration

6/25/2020 2:21 PM

Last time we checked in on AbbVie Inc (NYSE:ABBV), the company announced an oncology collaboration with biotech company Genmab (GMAB). Today, the drugmaker agreed to another collaboration, this time w...

Biotech Stock Stays Hot After Cancer Drug Collaboration

https://www.schaeffersresearch.com/content/news/2020/06/10/abbv

6/10/2020 11:00 AM

The shares of biopharmaceutical company AbbVie Inc (NYSE:ABBV) are up 2.1% at $98.16 at last check, after announcing an oncology collaboration with Genmab (GMAB). The companies will work together to d...

Reata Pharmaceuticals Options Hot as Shares Skyrocket

https://www.schaeffersresearch.com/content/options/2019/10/15/reata-pharmaceuticals-options-hot-as-shares-skyrocket

10/15/2019 10:10 AM

The shares of Reata Pharmaceuticals Inc (NASDAQ:RETA) have skyrocketed 46.7% to trade at $147.57, and earlier touched a record high of $149.80, thanks to strong data on the company's degenerative n...

PEOPLE ALSO SEARCH FOR

-intraday-options-activity